Clinical characteristics of Peutz-Jeghers syndrome in Korean polyposis patients

H S Choi1, Y J Park, E G Youk

  • 1Department of Surgery, Cancer Research Institute, Seoul National University, College of Medicine, Korea.

Insights

Peutz-Jeghers syndrome patients frequently experience surgical emergencies due to polyps. This study highlights a significant risk of early-onset malignancies in Korean patients, emphasizing the need for lifelong surveillance.

Area of Science:

  • Genetics and Hereditary Diseases
  • Gastroenterology
  • Oncology

Background:

  • Peutz-Jeghers syndrome (PJS) is an inherited disorder.
  • It causes hamartomatous polyps and mucocutaneous pigmentation.
  • PJS patients face risks of surgical emergencies and increased cancer risk.

Purpose of the Study:

  • To define the clinical characteristics of PJS in Korean patients.
  • To investigate the incidence and age of onset of malignancies in PJS.

Main Methods:

  • Retrospective analysis of 30 Korean PJS patients.
  • Review of clinical data, polyp locations, surgical history, and malignancy development.
  • Family history assessment for PJS and associated cancers.

Main Results:

  • Median age of patients was 23.5 years; symptoms began at 12.5 years.
  • Mucocutaneous pigmentation was present in 93% of patients.
  • Small bowel cancers (4) and breast cancer (1) were diagnosed in probands at a mean age of 36.
  • Cancers were also observed in first-degree relatives.

Conclusions:

  • PJS in Korea presents with characteristic polyp burden and pigmentation.
  • Early-onset malignancies, including small bowel and breast cancer, are a significant concern.
  • Early and continuous patient monitoring is crucial for managing surgical risks and cancer surveillance.

Related Concept Videos

Pleiotropy01:47

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...